Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in Mycobacterium abscessus complex isolates and evaluation of the accumulation of intrinsic macrolide resistance

被引:6
作者
Yoshida, Shiomi [1 ]
Tsuyuguchi, Kazunari [1 ]
Kobayashi, Takehiko [2 ]
Inoue, Yoshikazu [1 ]
Suzuki, Katsuhiro [2 ]
机构
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan
[2] Natl Hosp Org Kinki Chuo Chest Med Ctr, Internal Med, Sakai, Osaka, Japan
关键词
Mycobacterium abscessus complex; macrolide; accumulation of intrinsic macrolide-resistance; erm(41); sequevar; SUBSP ABSCESSUS; TREATMENT OUTCOMES; BOLLETII; ERM(41);
D O I
10.1099/jmm.0.001326
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction. Mycobacterium abscessus complex (MABC) is an infectious agent associated with macrolide resistance and treatment failure. Hypothesis/Gap Statement. Despite drug-susceptibility testing for MABC isolates including clarithromycin (CAM), long-term treatment with azithromycin (AZM) for MABC disease is recommended. Aim. We compared phenotypic and genotypic resistance to AZM and CAM in clinical isolates and evaluated the accumulation of intrinsic macrolide resistance (AIM) and morphological changes by macrolides exposure. Methodology. Forty-nine isolates were characterized regarding erm(41) sequevars. Sequencing data were compared to the nucleotide sequence of rrl and whiB7. The AIM MIC was performed in three reference strains and 15 isolates were randomized [each set of five isolates with M. abscessus subsp. abscessus (MAA) T28, MAA C28 and subsp. massiliense (MAM)]. Results. The 49 isolates were distributed as 24 MAA T28, 5 MAA C28 and 20 MAM. The MIC50 values to CAM at day 3 in MAA T28, C28 and MAM were 1, 0.12 and 0.12 mu g ml(-1), while those at day 14 were 32, 0.5 and 0.12 mu g ml(-1), respectively. The AZM-MIC50 values at day 3 of the above isolates were 4, 0.25 and 0.5 mu g ml(-1), while those at day 14 were >64, 0.5 and 0.5 mu g ml(-1), respectively. Neither mutations in rrl of MAA T28 with acquired resistance nor deletions in whiB7 of MAA T28 without inducible resistance were observed. For AIM MIC, MAA T28 showed that the time-to-detection of AZM resistance was significantly faster over that of CAM (P<0.05). Morphological changes were not determined in all isolates. Conclusion. Our findings did not support the suggestion for the preferential use of AZM for, at least, MAA T28 disease due to the high-level MIC value and the increased AIM. The long duration of AZM-based treatment eventually may favour the emergence of isolates with a high-level of intrinsic resistance.
引用
收藏
页数:9
相关论文
共 24 条
[1]   Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing [J].
Bastian, Sylvaine ;
Veziris, Nicolas ;
Roux, Anne-Laure ;
Brossier, Florence ;
Gaillard, Jean-Louis ;
Jarlier, Vincent ;
Cambau, Emmanuelle .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) :775-781
[2]   Utility of Sequencing the erm(41) Gene in Isolates of Mycobacterium abscessus subsp abscessus with Low and Intermediate Clarithromycin MICs [J].
Brown-Elliott, Barbara A. ;
Vasireddy, Sruthi ;
Vasireddy, Ravikiran ;
Iakhiaeva, Elena ;
Howard, Susan T. ;
Nash, Kevin ;
Parodi, Nicholas ;
Strong, Anita ;
Gee, Martha ;
Smith, Terry ;
Wallace, Richard J., Jr. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (04) :1211-1215
[3]   Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massillense Infection and Inducible Resistance [J].
Choi, Go-Eun ;
Shin, Sung Jae ;
Won, Choul-Jae ;
Min, Ki-Nam ;
Oh, Taegwon ;
Hahn, Mi-Young ;
Lee, Keehoon ;
Lee, Soo Hyun ;
Daley, Charles L. ;
Kim, Seonwoo ;
Jeong, Byeong-Ho ;
Jeon, Kyeongman ;
Koh, Won-Jung .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (09) :917-925
[4]  
Daley CL, 2020, CLIN INFECT DIS, V71, pE1, DOI 10.1093/cid/ciaa241
[5]   Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates [J].
Guo, Qi ;
Chen, Jianhui ;
Zhang, Shaoyan ;
Zou, Yuzhen ;
Zhang, Yongjie ;
Huang, Dongdong ;
Zhang, Zhemin ;
Li, Bing ;
Chu, Haiqing .
INFECTION AND DRUG RESISTANCE, 2020, 13 :447-454
[6]   British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) [J].
Haworth, Charles S. ;
Banks, John ;
Capstick, Toby ;
Fisher, Andrew J. ;
Gorsuch, Thomas ;
Laurenson, Ian F. ;
Leitch, Andrew ;
Loebinger, Michael R. ;
Milburn, Heather J. ;
Nightingale, Mark ;
Ormerod, Peter ;
Shingadia, Delane ;
Smith, David ;
Whitehead, Nuala ;
Wilson, Robert ;
Floto, R. Andres .
THORAX, 2017, 72 :ii1-ii64
[7]  
Hurst-Hess K, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01347-17, 10.1128/aac.01347-17]
[8]   Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections [J].
Jeong, Suk Hyeon ;
Kim, Su-Young ;
Huh, Hee Jae ;
Ki, Chang-Seok ;
Lee, Nam Yong ;
Kang, Cheol-In ;
Chung, Doo Ryeon ;
Peck, Kyong Ran ;
Shin, Sung Jae ;
Koh, Won-Jung .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 60 :49-56
[9]   Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease [J].
Koh, Won-Jung ;
Jeong, Byeong-Ho ;
Kim, Su-Young ;
Jeon, Kyeongman ;
Park, Kyoung Un ;
Jhun, Byung Woo ;
Lee, Hyun ;
Park, Hye Yun ;
Kim, Dae Hun ;
Huh, Hee Jae ;
Ki, Chang-Seok ;
Lee, Nam Yong ;
Kim, Hong Kwan ;
Choi, Yong Soo ;
Kim, Jhingook ;
Lee, Seung-Heon ;
Kim, Chang Ki ;
Shin, Sung Jae ;
Daley, Charles L. ;
Kim, Hojoong ;
Kwon, O. Jung .
CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) :309-316
[10]   Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus [J].
Koh, Won-Jung ;
Jeon, Kyeongman ;
Lee, Nam Yong ;
Kim, Bum-Joon ;
Kook, Yoon-Hoh ;
Lee, Seung-Heon ;
Park, Young Kil ;
Kim, Chang Ki ;
Shin, Sung Jae ;
Huitt, Gwen A. ;
Daley, Charles L. ;
Kwon, O. Jung .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (03) :405-410